Artigo Acesso aberto Revisado por pares

Analysis of genetic and phenotypic heterogeneity in juvenile polyposis

2000; BMJ; Volume: 46; Issue: 5 Linguagem: Inglês

10.1136/gut.46.5.656

ISSN

1468-3288

Autores

K Woodford-Richens, Steve Bevan, Michael Churchman, B L Dowling, Daniel Jones, C. Gail Norbury, Shirley Hodgson, Devendra Desai, Kay Neale, R K S Phillips, Joanne Young, Barbara Leggett, Malcolm G. Dunlop, Paul Rozen, Charis Eng, David Markie, Miguel A. Rodrı́guez-Bigas, E. Sheridan, Takeo Iwama∥, Diana Eccles, G. T. Smith, Jin Cheon Kim, Kyung Mo Kim, Julian R. Sampson, D. Gareth Evans, Sabine Tejpar, Walter F. Bodmer, Ian Tomlinson, Richard S. Houlston,

Tópico(s)

Chronic Lymphocytic Leukemia Research

Resumo

BACKGROUND Juvenile polyposis syndrome (JPS) is characterised by gastrointestinal (GI) hamartomatous polyposis and an increased risk of GI malignancy. Juvenile polyps also occur in the Cowden (CS), Bannayan-Ruvalcaba-Riley (BRRS) and Gorlin (GS) syndromes. Diagnosing JPS can be problematic because it relies on exclusion of CS, BRRS, and GS. Germline mutations in the PTCH , PTEN and DPC4 ( SMAD4) genes can cause GS, CS/BRRS, and JPS, respectively. AIMS To examine the contribution of mutations in PTCH , PTEN , and DPC4 ( SMAD4) to JPS. METHODS Forty seven individuals from 15 families and nine apparently sporadic cases with JPS were screened for germline mutations in DPC4 , PTEN , and PTCH . RESULTS No patient had a mutation in PTEN or PTCH . Five different germline mutations were detected in DPC4 ; three of these were deletions, one a single base substitution creating a stop codon, and one a missense change. None of these patients had distinguishing clinical features. CONCLUSIONS Mutations in PTEN and PTCH are unlikely to cause juvenile polyposis in the absence of clinical features indicative of CS, BRRS, or GS. A proportion of JPS patients harbour DPC4 mutations (21% in this study) but there remains uncharacterised genetic heterogeneity in JPS.

Referência(s)